In a major milestone for the country’s pharmaceutical industry, Novartis Bangladesh Ltd. has officially been renamed Nevian Lifescience PLC, following the historic acquisition of its majority shares by Radiant Pharmaceuticals Limited from Novartis AG Switzerland.
This transition has been achieved after fulfilling all statutory and regulatory requirements, ensuring a seamless and fully compliant process. Importantly, the shareholding status of Bangladesh Chemical Industries Corporation (BCIC) in the company remains unchanged.
A Legacy of Over 250 Years
Novartis and its predecessor companies have a global history spanning more than 250 years of scientific innovation and healthcare leadership.
In Bangladesh, operations began in 1973 with the establishment of Ciba-Geigy (Bangladesh) Limited as a joint venture with BCIC. Following the global merger of Ciba-Geigy and Sandoz AG in 1996, the company became Novartis (Bangladesh) Limited.
With Novartis AG’s recent decision to divest its stake in Bangladesh, Nevian Lifescience PLC now takes the helm — committed to carrying forward this rich heritage with a renewed vision, purpose, and focus on healthcare innovation.
Commitment to Patients and Quality
Nevian Lifescience PLC assures patients and healthcare professionals that there will be no disruption in the availability of medicines. Novartis’ global brands will continue to be manufactured under license, following the same processes, same quality standards, and at the same facilities. Additionally, imports and distribution of Novartis’ innovative life-saving medicines will continue under the Nevian Lifescience PLC banner.
Musawath Shams Zahedee, Managing Director of Nevian Lifescience PLC, stated:
“Nevian represents continuity of the legacy and commitment for a better tomorrow. While the name is new, our promise remains unchanged — to ensure and expand access to trusted, life-saving medicines for patients in Bangladesh and beyond.”
Global Quality and Local Strength
The company has already aligned with Swiss pharmaceutical giant Sandoz to continue supplying products to global markets and now envisions expanding exports to the USA, Europe, and other developed countries. This positions Bangladesh as a dependable global hub for high-quality pharmaceutical products.
Commitment to Safety, Quality, and Sustainability
Nevian Lifescience PLC remains committed to the highest standards of product quality, patient safety, and environmental responsibility. The company continues to strengthen its pharmacovigilance systems to monitor product quality and adverse reactions.
Read Also:
- World Pharmacists Day 2025: Think Health, Think Pharmacist
- Russia’s Cancer Vaccine Enteromix Shows 100% Success in Early Trials
For reporting product quality issues or adverse reactions:
Product Quality: quality@nevian.com.bd
Pharmacovigilance: pv.safety@nevian.com.bd
Corporate & Manufacturing Addresses
Corporate HQ: Tower One One Seven (Level 5), Plot #117/A, Tejgaon Industrial Area, Dhaka 1208, Bangladesh
Manufacturing Plant: Tongi Plant, Squibb Road, Cheraq Ali Bazar, Tongi Industrial Area, Gazipur 1711, Bangladesh
Key Message
Novartis Bangladesh has undergone a rebranding, now operating as Nevian Lifescience PLC, which underscores its dedication to innovation and excellence in the pharmaceutical industry. This transition reflects the company’s commitment to enhancing patient safety and product quality, positioning Nevian Lifescience PLC for significant future contributions to healthcare in Bangladesh and beyond.
Abdus Sobhan Salim is professional experienced pharmacist in pharmaceuticals, author and founder of pharmabossbd.com, the Bangladeshi pharmaceutical blogger since 2019.
